AdvanSix Inc. (ASIX) Earnings Call Transcript & Summary

Good morning, and welcome to the AdvanSix Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Adam Kressel, VP, Investor Relations and Treasurer.

Thank you, Andrew. Good morning, and welcome to AdvanSix's fourth quarter 2022 earnings conference call. With me here today are President and CEO, Erin Kane; and Senior Vice President and CFO, Michael Preston. This call and webcast, including any non-GAAP reconciliations, are available on our website at investors.advansix.com. Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and of our business as we see it today. Those elements can change and the actual results could differ materially from those projected, and we ask that you consider them in that light. We refer you to the forward-looking statements included in our press release and earnings presentation. In addition, we identify the principle risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K as further updated in subsequent filings with the SEC. This morning we will review our financial results for the fourth quarter and full year 2022 and share our outlook for our key product lines and end markets. Finally, we'll leave time for your questions at the end. So with that, I'll turn the call over to AdvanSix's President and CEO, Erin Kane.

Thanks, Adam, and good morning, everyone. Thank you for joining us and for your continued interest in AdvanSix. As you saw in our press release, AdvanSix delivered record annual sales, earnings and cash flow performance in 2022, reflecting strong commercial execution. This builds on our track record of performance with earnings growth for the third consecutive year. Now let me share a few highlights before Mike covers the details of our financials in a moment. We continue to benefit from our diversified portfolio and integrated, efficient and cost advantaged business model. In the fourth quarter, our strong commercial performance helped to offset pockets of soft end market demand, customer destocking and operational challenges. Cash flow generation continued to be robust to close out the year, supporting disciplined and value-accretive capital deployment. In 2022, we enhanced our capital deployment with the acquisition of U.S. Amines and an increase in return of cash to shareholders through share repurchases and an increased dividend, while further reducing debt. Our Board of Directors has approved an additional $75 million share repurchase authorization, reinforcing the flexibility we've built into our capital allocation strategy. We've also had several exciting recognitions recently. I am pleased to announce that we continued to be recognized for our strong corporate governance and focus on sustainability. AdvanSix was recently awarded its second consecutive Platinum Rating for Corporate Social Responsibility from Eco Vadis. This continues to rank us among the top 1% of all companies assessed. In addition, the National Association of Corporate Directors, New Jersey Chapter, has recognized AdvanSix as a Public Company Board of the Year. Leading with transparency and accountability enables us to deliver better results for our stakeholders, while driving our long-term strategies forward. Now looking to 2023, we believe that we are well positioned for another year of differentiated performance supported by a diverse product portfolio, continued strong agricultural and fertilizer industry fundamentals and the resilience of our business model. Roughly 1/3 of our portfolio is in the agricultural sector, including ag chemicals. And our position in this attractive market has extended even further through our acquisitions of U.S. Amines as well as the packaged ammonium sulfate business, CIS, and organic investments to expand our high-valued granular ammonium sulfate. While we do anticipate the challenges of an uncertain environment and expect demand weakness in several market segments within our nylon and chemical intermediate product lines, we remain confident in our demonstrated ability to execute and perform through various macroeconomic cycles. We have structurally improved the earnings power of this business and our competitive advantage will support us running disproportionately higher plant production rates in 2023 to complement our strong commercial performance. Our healthy balance sheet will also serve us well and continues to support our ability to deploy capital and maximize shareholder value. With that, I'll turn it over to Mike to discuss the financial details of the quarter.

Thanks, Erin, and good morning. I'm now on Slide 4 where I'll provide a summary of the full year 2022 financial results. As Erin pointed out, it was terrific performance across the board as commercial -- strong commercial execution more than offset volume declines and raw material inflation, resulting in significant top and bottom line growth. Sales of $1.9 billion, adjusted EBITDA of $308 million, adjusted earnings per share of $6.28 and free cash flow of $184 million, all represented record annual performance. We've now increased earnings for 3 consecutive years and believe this represents differentiated performance versus our peers. Let's turn to Slide 5 to recap the fourth quarter results. Sales of $404 million decreased approximately 5% in the fourth quarter, primarily driven by a 15% decline in volume. Pockets of soft end market demand and customer destocking contributed to the volume decline. Pricing was favorable by 6%, comprised of an increase in market base pricing of 10%, primarily driven by higher ammonium sulfate pricing. This was partially offset by a 4% decline in raw material pass-through pricing following a net cost decrease in benzene and propylene. The acquisition of U.S. Amines added approximately 4% of sales as well. Adjusted EBITDA was $67 million. I will highlight the key year-over-year variances on the next slide. Adjusted earnings per share was $1.27, up 44% versus the prior year. And finally, free cash flow reached $41 million, up 194% versus the prior year. Cash flow from operations of $70 million increased $36 million, primarily due to higher net income. Capital expenditures of $28 million in the quarter increased $9 million versus the prior year. Let's turn to Slide 6. Here we highlight a few of the key drivers of our fourth quarter adjusted EBITDA performance year-over-year. Pricing of raw materials was a $44 million benefit. Tracking our key variable margin drivers, ammonium sulfate on a net price over natural gas and sulfur basis, remained positive year-over-year, reflecting the strong underlying ag environment as well as our ability to drive our sulfur nutrient value proposition. Chemical intermediates price of our raw spread was positive year-over-year as well, largely reflecting acetone margin over following propylene costs. Performance across our caprolactam and nylon portfolio over our key raws was roughly flat year-over-year. Volume was approximately $26 million unfavorable in the quarter, primarily due to customer destocking and soft end market demand across some of our portfolio. We saw the most impact across our nylon and chemical intermediates product lines, particularly products serving consumer durables and building and construction end markets. The impact of our planned plant turnarounds was a known tailwind to our year-over-year performance as we had no turnaround activities in the fourth quarter of '22 versus approximately $80 million in the fourth quarter of 2021. As you may recall, we completed our 2022 multi-site planned plant turnaround in the third quarter of 2022. Finally, we saw approximately $21 million in higher cost and plant spend driven by an increase in gas utility prices and an increase in non-raw material inflation, primarily on transportation costs. Operational performance in December in particular was impacted by extremely cold temperatures across our integrated value chain. As a result, our quarterly utilization was roughly flat to the fourth quarter of 2021 and below historical run rates for a non-outage quarter. Let's turn to the next slide. On the left side of Page 7, we've highlighted our robust 2022 cash flow generation, which was primarily driven by net income of 172 and $39 million favorable impact of net working capital, including approximately $32 million of ammonium sulfate pre-buy cash advances in the fourth quarter. CapEx was approximately $89 million for the year, driven by a planned increase in maintenance and health, safety and environmental projects. I would highlight that over the last 12 months, our free cash flow yield is roughly 17% and our free cash flow conversion is 107%, which reflects a healthy cash flow generation and quality of earnings our business model delivers. On the right side of the page, we've depicted our capital allocation since 2017. As you can see, we've enhanced our capital deployment in 2022 with the acquisition of U.S. Amines and a meaningful step-up in cash return to shareholders, all while further reducing debt levels. In 2022, we returned a combined $49 million to shareholders by way of dividends and share repurchases. Our next quarterly dividend of $0.145 per share will be made payable on March 17th for shareholders as of record date March 3rd. We are in a favorable position with our healthy balance sheet, particularly as we enter a more uncertain macro environment in 2023. Now let's turn to Slide 8. We remain disciplined in our approach to investing in the business for long-term sustainable returns. We generated strong returns on invested capital and have outperformed peers, which is a testament to the earnings power created from our investments along with our operational and commercial execution. We continue to focus on improving through-cycle profitability across the business with the goal of generating higher lows and higher highs. We expect an increase in capital expenditures in 2023, which include -- which will include a mix of critical infrastructure, other maintenance and growth and cost savings projects as well. These projects are vital for safe, sustainable and consistent long-term performance. Our growth project pipeline, amongst others, includes projects to support our multi-year goal to double earnings of the U.S. Amines business and expand our granular ammonium sulfate conversion. So with that, let me turn the call back to Erin.

Thanks, Mike. I'm now on Slide 9 to discuss each of our key product lines. Starting with nylon. The global composite price raw spread remained relatively flat sequentially and year-over-year in the fourth quarter. Asia spreads, however, declined more severely as COVID lockdowns in China led to weaker demand and excess supply moving to other regions at lower prices. Textile demand declines in Asia have impacted global nylon industry supply and demand conditions. While not the significant end use for AdvanSix sales directly, textiles represents the largest nylon end use globally and are impacted by greater consuming U.S. and Europe markets, which face increased uncertainty with respect to consumer spending on goods. Now from an end market perspective in North America, the situation is quite mixed. In the fiber and filament space, where we serve our carpet customers, we've seen a slowdown through the chain with continued inventory corrections, which we expect to continue in the first half of the year. In engineered plastics, while we're expecting sequential volume improvement from the fourth quarter into 2023, the price compression out of Asia is impacting global pricing. Now as a reminder, roughly 30% of our nylon portfolio serves this space into applications such as auto, consumer and other industrial goods. And here, we are seeing resin pricing moving at a multiple lower than the change of raw material input costs. And then as a bright spot, packaging continues to be a stable end market, and despite some inventory drawdowns at year end, remains a resilient end application for our business. We continue to focus on being a reliable North American supplier. And we'll optimize our mix, as we have in the past, to meet customer demand and navigate through these dynamics. Moving to ammonium sulfate. We've witnessed nitrogen prices come down from significantly higher levels seen earlier in 2022. Nitrogen supply availability as well as lower energy costs, particularly in Europe, have supported a reduction in nutrient pricing. While it is not uncommon to see a seasonal low in demand exiting the year, we remain confident that the resilient underlying agricultural industry fundamentals, supported by crop prices, farmer profitability, fertilizer affordability, expected planted acres and stock-to-use ratios will continue to support strong nutrient demand. And so despite some cautious buying behavior ahead of the season, we remain well positioned to serve our key customers as we move into the heart of the domestic planting season. And lastly, turning to chemical intermediates. Industry realized acetone prices over refinery-grade propylene costs improved year-over-year and sequentially in the fourth quarter. Propylene costs have continued to trend lower on ample supply over the last few months. While acetone demand downstream has seen some softness into the large buyer applications, we see supply is balanced to tight, supported by stable acetone imports into the U.S. and lower phenol operating rates globally on reduced demand into building and construction and other industrial applications. I'll point out here that our integrated operating model serves us well in industry dynamics like these. Now let's turn to Slide 10 to discuss our outlook. We expect performance in 2023 to once again demonstrate the resilience of our business model and our ability to navigate through the challenges of an uncertain environment. We expect favorable underlying agricultural industry fundamentals to continue. We also expect the balanced supply and demand conditions for North American acetone given lower phenol industry operating rates globally. We'll also have the potential for some tightness, particularly in the first half of 2023. We do anticipate headwinds in consumer durables and building construction end markets across our nylon and other chemical intermediates product lines. And as I shared earlier, this will have implications for both volume and price. Now for reference, we've shared our sales by end market exposure on the left-hand side of the page. We are a diversified chemistry company. And the range of our end market exposure helps insulate the company from significant variability in any one product line, as demonstrated by our results in several environments. Operationally, we continue our focus on safe, stable and sustainable performance, while driving less variability in utilization rates, which in turn drives our improved customer experience and higher returns for the business. Our integrated value chain and competitive cost advantage enables us to target, running our plants at those disproportionately higher rates than the industry on average. For the full year 2023, we're projecting CapEx spend to be approximately $110 million to $120 million. This range reflects higher spend to support critical infrastructure improvements, other maintenance as well as additional growth and cost savings projects. We expect the pre-tax impact of planned plant turnarounds to be in the range of $20 million to $33 million in 2023, a tailwind compared to approximately $50 million for the full year 2022. And lastly, we expect our effective tax rate for the year to be approximately 24% and anticipate cash pension contributions to be approximately $0 million to $5 million, following $20 million in contributions in 2022, bringing our defined benefit plan to a nearly fully funded status. Let's turn to Slide 11 to wrap up before moving to Q&A. As we've shared previously, we believe that AdvanSix offers a compelling investment thesis over the short, medium and long-term. Our leading North American position and advantaged asset base, coupled with our efficient and lean business model, provide inherent competitive advantages. And we're aligned to the diverse set of end market applications. As I pointed out and reiterate again, roughly 1/3 of our portfolio is supported by exposure to strong agricultural fundamentals. We also continue to invest for long-term growth across the broader portfolio into applications such as paints and coatings, electronics and other solvents. Supplementing our exposure to these diverse end use applications, we seek to enhance our sales mix through our differentiated product portfolio, which are margins that are roughly twice our average base business gross margins and also continue to make smart and disciplined investments in our assets to sustain and improve throughput and profitability. We have substantially increased the earnings power of this business with our focus on through-cycle profitability. Lastly, our enhanced capital allocation framework provides upside and optionality for further value creation. So long, we feel very good about the strategies we've implemented, which continue to support expectations for AdvanSix's long-term sustainable performance. So with that, Adam, let's move to Q&A.

Andrew, please open the line for questions.

[Operator Instructions] The first question comes from Charles Neivert with Piper Sandler.

I have a quick question. In terms of the CapEx, how do I look at that across the course of the year? Is it going to be fairly evenly spread out? Is there one or 2 quarters that are going to be heavier than others? And then in terms of the work getting done, does any of that bring sort of increased efficiencies that might lead to maybe a small tweak in capacity or anything of that nature that comes or is it just more of long-term maintenance that has to get done to improve the existing equipment, et cetera?

Yes, Charlie, typically, the CapEx spend run rates are heavier in the second half than the first half as we sort of ramp up here from the $90 million levels in 2022 to roughly the $110 million to $120 million in 2023. And again, some of the increase in the spend is critical infrastructure work at our sites, other repair and maintenance projects, which we've demonstrated has an effect and improves our safe and stable operations, support safe and stable operations going forward here. So that's what I would expect. So probably in the sort of 60% range in the second half, 60% to 70% second half versus first half.

And then in terms of the movement of product that you guys are seeing, meaning, I'm assuming China is exporting where they typically haven't exported because they had some excess production and they want to keep running. I mean, do you see that -- has that the cadence of that product or has that changed at all over the last, let's say, a couple of months or is it maintaining the level -- the higher level? And looking at it, going forward, do you have any idea of when things are -- might come back to, let's say, their more normal state or pre-existing?

Certainly, we've seen this trend. Again, it's a components of factors, as you pointed out here over the last couple of months, probably starting late Q3 through Q4 coming into the start of the year. And it's the lower -- certainly, demand in the region now impacting those trade flows. So we're also seeing not just Chinese resin, but also certainly, resin from other countries being exported into the European Union. Obviously, that started in 2022, certainly with the higher cost considerations in Europe and the pullback on their operating rates moving into South America and Mexico as well. And we've also seen downstream products, including compounded resins, all out of the Asia moving into America and Mexico. Certainly, OEMs have global footprint. So there is this pressure of how do they compete and how -- what is the consideration against the collective set of overseas assets. So certainly, we're watching for the rebound, certainly a recovery in the region obviously to pull their volumes back up. You have low operating rates starting to be seen in -- outside of China. They're about 50%. So hopefully that will contribute as well. So I think it will certainly be a first half consideration how long it moves into that. Certainly, there's contracted volume here for us, but there's also freely negotiated and spot-oriented products as well. But again, we see this predominantly in that engineered plastic space. And certainly, freight as well just is another component of factors. Freight rates dropped dramatically in the back half of the year and sort of making transport, which may have been -- would have impacted sort of landed cost has moderated here as well.

[Operator Instructions] The next question comes from Vincent Anderson with Stifel.

You made a point to come out and say a couple of times that you'll be running the plants very hard next year, harder than this year and that's kind of despite this demand outlook. In the past, that's involved things like spot export sales, but you've also mentioned, over the last couple of years, an improved U.S. market share in nylon specifically. And you also have a balance sheet that can handle greater inventory builds, if you needed to lean on that. So I'm just wondering how your commercial strategy may look different in this particular downturn versus what we observed in prior years?

Certainly happy to sort of clarify and provide a little bit more color around the statement. Certainly, as we have discussed throughout sort of 2022, we didn't have as strong as an operational year as we normally would have. I mean, certainly, relative to all the strategies we have in place around, say, sustainable operations that it continues to be a core focus for us. The commentary around the returning of plant utilization rates is again ensuring that our strategies are delivering the outcomes we expect. Our integrated value chain allows us to run naturally higher rates to start. So let's kind of maybe break it down just quickly here. So our phenol plants are operating at least 15% higher rates than other North American players right now because of our integrated position on phenol in a market where phenol demand is off, right? So that again allows us to have the presence in the acetone market, which again, serves us well. In Hopewell, running caprolactam and ammonium sulfate, we have a [indiscernible] and our confident in a strong spring season relative to demand for fertilizer. So again, it's important for us to get our performance back and to ensure that we are running to fulfill our customer demands there, obviously then -- and moving through for caprolactam and nylon. Here, we have 2 things going on. In some cases, it's a volume consideration, as I pointed out, mostly in fiber and filament. It's a pricing consideration associated with engineering plastics and packaging is remaining robust and resilient. So I think what you'll see us do is, yes, we have mix as a lever for this organization and for this enterprise. But up to and including, as you say, thinking about the right inventory builds against the right margin sales, those are all things that go into our calculus. And we have all those degrees of freedom of which to pull and operate through this market, which I think differentiates us and separates us from other competitors in the space.

And if my math is correct, it's maybe a big if on a Friday, but it looks like your Amines' revenues were actually up sequentially in the fourth quarter. Do I have that right? And if so, can you talk about what was going on there?

Yes. When you look at the third to fourth quarter sequential bridge here, you'll note that roughly a percentage point on total revenue was driven by M&A, and that's all U.S. Amines. And some of that is, they're serving -- when you look at the ag sector and the seasonality associated with that, that can impact the timing of revenues from quarter-to-quarter. So more of this was bit of a seasonal improvement and we would expect also the first half of the year to be strong as the season at a high level typically in the first half.

And actually, a quick one in the similar vein. Your cash advances picked up quite a bit versus prior years, obviously, excluding last year. Can you speak to how much of that represented a higher percentage of your 2Q fertilizer volumes versus just price being higher in that dollar amount?

Sure. We can certainly provide some clarity there. So again, we did proceed with a pre-buy this year as it was in the interest of our customers and the desire to proceed with one. What we would say is that the volume for the pre-buy would be, on average, consistent with the pre-buys that we conducted in the years prior to last year. So let's call it, '19-'20 and '20-'21. The difference really being the market price being higher than that timeframe.

The next question comes from David Silver with CL King.

I'm going to warn you in advance, I've had an unusual morning. So I joined the call late. So I'm going to make you repeat yourself on 1 or 2 things. But could we just start -- could you just summarize what the operational challenges were this quarter? Again, I wasn't able to listen to your opening remarks. But both in the -- if you could just characterize the source of it? And then if you quantified it at all, I'd appreciate you just summarize, including that comment as well.

Yes. Sure, David. Happy to provide a little bit more color. Where we saw some more of the lower utilization rates relative to what we had planned was later in the quarter, particularly in December. You may recall, we hit a string of weather across the country that had some very frigid temperatures that impacted not only us, but also others in the industry. And that resulted in us running at lower rates than what we would have liked. And so that was the main driver in the quarter. And we're comfortable that we took all the necessary actions to get back up to plan here and we'll -- and do expect a better performance here as we get into the first quarter.

I wanted to ask a question about U.S. Amines. So it's been -- you've owned it now for 3 full quarters. And I was just wondering if you could just talk about the integration, talk about the synergies you've been able to realize cost, but also revenue if there are some crossover benefits? And then with your CapEx spend for next year, the higher CapEx spend, how much, if anything, of that is really dedicated to executing on some comments you made in the past about there being some pretty straightforward expansion opportunities there?

Sure, David. So yes, we're actually coming up on a year, which is terrific. And I would share that the integration has gone well. The functional integration is largely complete, which is great. It went into the plan as has sort of the last couple of quarters relative to our expectations in bringing the portfolio into our fold. So again, we're pleased with where we sit. We're on target to where we were expecting to be. And so that's important. One of the considerations when we announced the acquisition was really around that this was a asset or a set of assets in a business that landed itself for future growth, right? So our primary focus was to begin executing against those projects where we saw opportunity to take the multi-faceted assets that they possess, which are more pots and pans oriented to expand capability sets and begin to use them in new and expanded ways. So again, the CapEx target -- again, CapEx here, the assets are not as CapEx-intensive as our other assets. So again, we have begun deploying against those projects to enable us to expand capability set. So there are number of amines that we can make, including cyclohexylamine, improving the production of isopropyl alcohol and things that are inside the views, other diamenes and we continue to have customers and potential customers reach out. And so again, that is where we are headed to relative to the value creation of the acquisition rather than more traditional sales synergies, as you asked about. So again, on track. I think as we continue to progress, we will be able to speak more about those items. But we are where we expected to be and continue to work that plan.

And just a follow-up on that. In the past, you've talked about, I believe, $200 million or so of specialty, specialty intermediate and other specialty product revenues or differentiated revenues. Where do you think that run rate is now? And what are your -- when you think about 2023, is that going to comprise a growing percentage of your overall revenues or overall earnings power in your estimation? What is the -- what is budgeted kind of for that clutch of differentiated products?

Again, certainly, we have been proud of the growth that we have seen really over the last 5 years, as we pointed out in prior sessions, significant growth in our both high-purity intermediates and high-value intermediates that are going into areas of paints and coatings and electronics, expanding and continuing to grow our wire and cable and copolymer sales and nylon. What I would say, David, is that while these are differentiated products, they're not necessarily immune per se to the global considerations and end market dynamics. So certainly, long-term trends for these applications are very positive. And it's why we've continued to invest and continue to think about our portfolios in these spaces. But they can have considerations for demand just like other applications. And so there's continued focus. But for instance, semiconductors, as things kind of move down and people are thinking about purchase of goods in 2023, may perhaps be at a different rate of growth than we've seen in the past few years. Europe has also seen a slowdown in paints, coatings and sealants. So again, this is a long-term focus for us. And I think that the kind of the key takeaway is that it's not entirely immune. But again, we expect these things to recover and continue to have those long-term opportunities for us.

I'm going to keep going if you don't mind. Everyone else had their first shot, so too bad for them. But I wanted to ask you a question about nylon, and in particular, I guess, the construction or related uses. And in North America, I guess, the residential construction side of things has slowed down a fair amount. And what do I know, but if the Fed is continuing to raise interest rates, I'm thinking that could have incremental negative effects, let's say, on mortgage rates and things like that. How do you think about marketing, I guess, or allocating your nylon capacity to different end markets? And what makes sense in a uncertain economic environment, but definitely one where residential construction seems to be on the downturn right now? I'll stop there.

No, as you said, certainly, residential construction is being hit more strongly than commercial. That said, nylon plays well into the commercial space. We would see that certainly areas like lodging, hospitality, these are areas where the consumer is still spending. We think about the latest reports, sales against leisure and hospitality and those types of services continue to be strong areas. It generates opportunities for continued remodeling and upgrades. So there is a mix, but certainly, residential -- that can be a challenge and certainly will be most impacted by inflation, consumer confidence, interest rates. And we see that in remodeling activity coming down, as you say, housing starts and certainly in existing home sales. But again, nylon focusing on that commercial space is going to be important for us as we navigate through the collective set of dynamics for this. Again, our assets to produce nylon have some flexibility. So again, it's one of those degrees of freedom that we have to manage mix along the way. Customers are still buying. We want to make sure that we are supporting those key folks. Opportunities around in the space of sustainability are becoming important as well. And so interest in our post-industrial recycled grades and post consumer recycled grades are going to be important here as they are in other applications as well. So again, at the end, we've got the flexibility of our assets. We've got sort of a mix of ensuring that we are capturing the commercial opportunities even as a smaller base residential impact on carpet may come into play. And then really ensuring that -- and we've proven this in the past that we can pull those levers and navigate through.

Probably nothing you haven't seen before, but interest rates have been so low recently. I don't know, I just wanted to hear you talk through that. One last question, and this has to do with Europe, and I guess, the impact of lower natural gas costs there on, I guess, global trade patterns. But I guess, natural gas has come well off of its spiking highs of the past year, year and a half. And I'm just wondering, since natural gas is used effectively for both fertilizers that could be produced in Europe as well as nylon and caprolactam, I mean, I'm just wondering, if you're seeing or anticipating any shift in trade patterns? In other words, import product that used to be exported to Europe imported into Europe may now get backed out. And just wondering, if you're seeing any of that on either nylon or in fertilizer to this point? And what might your expectations be going forward?

Certainly, as the general situation has improved in Europe, as you pointed out on the input cost improving the sentiment to produce in a number of chains, they still have sort of reduced demand in general and weakness that they're going to have to sort through in a number of end applications, as we've touched on. So it's one where -- yes, there's -- when we think about production of nutrients, those rates have picked up primarily for certainly the regional demand there. We'll see, like I said, it's -- Europe is probably 50% capacity utilization as we know it right now in caprolactam through the chain, but then this is a space where global trade is understood. And certainly, things moving in from Asia went in heavily last year as well and we'll resort themselves accordingly as we move forward. It's hard to say that there is a definitive move here one way or the other, but again, these are global markets on that sense, but certainly, they have their regional nuances as well. So Europe is certainly a buyer's market for nylon. So there's going to be produced -- certainly, it's a pressure there just because you have a length of supply. And in fertilizer, you've got global buying just slowing down in general. And so again, nitrogen capacity there, we would put it at about 70%. So like anything else, this is what the world is going to have to navigate through both globally and regionally I think moving forward as we progress through the year.

Yes. And even though natural gas prices have come down, there's still -- when you think of those prices relative to history and on a relative basis to like the U.S., they're still high, right? So that's just another consideration there, Dave.

No, there definitely still is that regional disparity, no question.

This concludes our question and answer session. I would like to turn the conference back over to Erin Kane for any closing remarks.

Thank you all again for your time and interest this morning. Despite the macro headwinds and operational challenges in the fourth quarter, our performance reflects the resilience of our business model and our ability to navigate and execute in a multitude of environment. Following the record performance in 2022, we look forward to continued execution of our strategic priorities in 2023 and are committed to delivering long-term value to our shareholders. With that, we look forward to speaking with you again next quarter. Stay safe and be well.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.